Evidence map›Paper›PMID 41606371›Full record

ArticleGenes and immunity2026

Association of tumour-associated macrophage states with nonconserved lncRNAs in lung cancer.

Yvessa Verheyden, Sonia Cinque, Daliya Kancheva, Jo A Van Ginderachter, Eleonora Leucci

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yvessa VerheydenLaboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.ORCID 0000-0003-3537-8217
Sonia CinqueLaboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.
Daliya KanchevaLab of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
Jo A Van GinderachterLab of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
Eleonora LeucciLaboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium. eleonora.leucci@kuleuven.be.

Funding

Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 1SC5122NOnderzoeksraad, KU Leuven (Research Council, KU Leuven) C16/19/006
6 · The paper itself

Abstract

Tumour-associated macrophages (TAMs) are central players in the tumour microenvironment, driving cancer progression and modulating immune responses. Renowned for their ability to rapidly adapt to environmental changes, TAMs can adopt a wide range of functional phenotypes. However, the regulatory mechanisms underlying this functional plasticity are still not fully understood. Long non-coding RNAs (lncRNAs), as key regulators of epigenetic and post-transcriptional processes, are increasingly recognized for their potential role in TAM polarization. In this study, we conducted a comprehensive comparative analysis of lncRNA expression in TAMs derived from both mouse and human lung carcinomas. Although we identified a small group of murine lncRNAs as potential human orthologs through orthogonal in silico approaches, the majority of murine lncRNAs lacked clear human equivalents. Overall, our findings reveal distinct lncRNA expression patterns in lung carcinoma mouse and human TAMs, underscoring the importance of utilizing human-based models to thoroughly investigate the roles of lncRNAs in immune regulation and bridge the translational gap between murine and human cancer immunology.

Indexed as

Lung NeoplasmsRNA, Long NoncodingTumor-Associated MacrophagesAnimalsGene Expression Regulation, NeoplasticHumansMiceTumor MicroenvironmentRNA, Long Noncoding

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.